:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Calvin M. Le, Xueyan Chen, Shunya Kodaira, Megan Othus, Margery Gang, Chris Davis, Ryan S. Basom, Sindhu Cherian, Roland B. Walter
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	HemaSphere
Online Access:	https://onlinelibrary.wiley.com/doi/10.1002/hem3.70310
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Inflammatory signaling in the pathogenesis of acute myeloid leukemia
by: Artemis Margrith Baumann, et al.
Published: (2025)

HLA diversity is associated with TKI response and treatment‐free remission in chronic myeloid leukemia
by: Charles Toulemonde, et al.
Published: (2025)

Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study
by: André Baruchel, et al.
Published: (2025)

Upregulation of ALDH1 as an adaptive epigenetic response to anthracyclines in acute myeloid leukemia
by: Francesco Leonetti, et al.
Published: (2025)

Cell surface surprise: NPM1 is an immune therapy target for acute myeloid leukemia
by: Hansen J. Kosasih, et al.
Published: (2025)

Neuroinflammatory changes in acute myeloid leukemia: Evidence for blood–brain barrier disruption and glial activation
by: Marta Febo, et al.
Published: (2026)

Integrating transcriptomic profiling and machine learning: A clinically actionable prognostic model for infant acute myeloid leukemia
by: Yu Tao, et al.
Published: (2025)

Minimal residual disease assessment following CD19‐targeted therapy in B‐cell precursor acute lymphoblastic leukemia using standardized 12‐color flow cytometry: A EuroFlow study
by: Martijn W. C. Verbeek, et al.
Published: (2025)

Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphoma
by: Daniel Pölöske, et al.
Published: (2024)

Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)
by: Martijn P. T. Ernst, et al.
Published: (2025)

Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)
by: Frank G. Rücker, et al.
Published: (2024)

Improved post‐transplant outcomes since 2000 for Ph‐positive acute lymphoblastic leukemia in first remission: A study from the EBMT Acute Leukemia Working Party
by: Ali Bazarbachi, et al.
Published: (2025)

Hyperdiploid acute lymphoblastic leukemia in children with LZTR1 germline variants
by: Lisa Zipper, et al.
Published: (2024)

Mutational signatures and kataegis in pediatric B‐cell precursor acute lymphoblastic leukemia
by: Rebeqa Gunnarsson, et al.
Published: (2025)

Dynamics of BCR::ABL1 transcript levels and clinical outcomes after switch to second‐line therapy in pediatric chronic myeloid leukemia
by: Stephanie Sembill, et al.
Published: (2026)

Ponalfil trial for adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia: Long‐term results
by: Josep‐Maria Ribera, et al.
Published: (2024)

Ex vivo drug responses and molecular profiles of 597 pediatric acute lymphoblastic leukemia patients
by: Anna Pia Enblad, et al.
Published: (2025)

Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B‐ALL, or T‐ALL
by: Roger Mulet‐Lazaro, et al.
Published: (2025)

Circulating tumor‐associated and neoantigen‐specific endogenous T cells in children treated for B‐acute lymphoblastic leukemia
by: Eliane Huwiler, et al.
Published: (2025)

Pharmacological inhibition of sclerostin protects bone from B‐cell acute lymphoblastic leukemia‐mediated destruction
by: Vincent Kuek, et al.
Published: (2026)

Combination of targeted pharmacotherapy and immunotherapy with anti‐CD19 CAR NK cells in acute lymphoblastic leukemia
by: Hanna Kirchhoff, et al.
Published: (2025)

Long‐term outcome of 2‐year survivors after allogeneic hematopoietic cell transplantation for acute leukemia
by: Marion Larue, et al.
Published: (2024)

TLX1 translocation variants and enhancer hijacking influence clinical outcome in T‐cell acute lymphoblastic leukemia
by: Estelle Balducci, et al.
Published: (2025)

Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia
by: Bela Patel, et al.
Published: (2024)

Genetic evolution and relapse‐associated mutations in adult T‐cell acute lymphoblastic leukemia patients treated in PETHEMA trials
by: Celia González‐Gil, et al.
Published: (2025)

TWIST2 high expression defines a novel subtype of B‐cell precursor acute lymphoblastic leukemia
by: Tao Zeng, et al.
Published: (2026)

Disease‐burden‐adapted immunotherapy protocol for primary refractory or high‐risk relapsed pediatric acute lymphoblastic leukemia
by: Sanaa Khan, et al.
Published: (2024)

An integrated classification of tumor suppressor IKZF1 inactivation and oncogenic activation in Philadelphia chromosome‐like acute lymphoblastic leukemia
by: Zicong Huang, et al.
Published: (2024)

Correction to “Genetic evolution and relapse‐associated mutations in adult T‐cell acute lymphoblastic leukemia patients treated in PETHEMA trials”
Published: (2026)

The ETO2 transcriptional cofactor maintains acute leukemia by driving a MYB/EP300‐dependent stemness program
by: Alexandre Fagnan, et al.
Published: (2024)

Parents' perception of treatment‐related toxicity in children treated according to the NOPHO ALL2008 protocol for acute lymphoblastic leukemia
by: Nina Mogensen, et al.
Published: (2024)

Activating mutations remodel the chromatin accessibility landscape to drive distinct regulatory networks in KMT2A‐rearranged acute leukemia
by: Qirui Zhang, et al.
Published: (2024)

The CD123 antibody–drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemia
by: Ben Watts, et al.
Published: (2025)

Absence of identifiable granulopoiesis at diagnosis of childhood acute lymphoblastic leukemia conveys an extremely high risk of early blood culture‐positive infection
by: Elli‐Maija Ukonmaanaho, et al.
Published: (2026)

Prospective phase II study of allogeneic hematopoietic stem cell transplantation with targeted busulfan, fludarabine, and etoposide conditioning in pediatric acute lymphoblastic leukemia
by: Kyung Taek Hong, et al.
Published: (2024)

Flow cytometry interference in patients treated with tafasitamab: Unraveling the diagnostic maze
by: Lisa Proost, et al.
Published: (2024)

Inhibition of the NLRP3 inflammasome using MCC950 reduces vincristine‐induced adverse effects in an acute lymphoblastic leukemia patient‐derived xenograft model
by: Hana Starobova, et al.
Published: (2025)

Enhanced potency of immunotherapy against B‐cell precursor acute lymphoblastic leukemia by combination of an Fc‐engineered CD19 antibody and CD47 blockade
by: Denis M. Schewe, et al.
Published: (2024)

High‐risk cytogenetic abnormalities in multiple myeloma: PETHEMA‐GEM experience
by: Veronica González‐Calle, et al.
Published: (2024)

Less is more: Depleting myeloid‐biased HSCs to restore immune function
by: Hansen J. Kosasih, et al.
Published: (2024)